Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Samsara BioCapital, LLC

Q3 2024 · 13F-HR

Samsara BioCapital, LLCholdings as filed

Filed 2024-11-14 · accession 0001104659-24-118933

$520.3M
Reported value
42
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
14179K101CRGXCARGO THERAPEUTICS INC$81.5M15.7%4,415,689CommonSOLE
603170101MLYSMINERALYS THERAPEUTICS INC$61.5M11.8%5,074,916CommonSOLE
80706P103SRRKSCHOLAR ROCK HLDG CORP$54.4M10.5%6,788,609CommonSOLE
64135M105NGNENEUROGENE INC$53.2M10.2%1,267,790CommonSOLE
022307102ALMSALUMIS INC$34.9M6.71%3,266,498CommonSOLE
03940C100ACLXGBXARCELLX INC$29.5M5.68%353,641CommonSOLE
52635N103LENZLENZ THERAPEUTICS INC$28.7M5.51%1,208,473CommonSOLE
65487U108NKTXNKARTA INC$17.0M3.27%3,768,035CommonSOLE
28658R106CLYMELIEM THERAPEUTICS INC$13.3M2.55%2,609,114CommonSOLE
G29687103AVDLAVADEL PHARMACEUTICALS PLC$12.7M2.44%967,527CommonSOLE
98985Y108ZYMEZYMEWORKS INC$12.6M2.41%1,000,000CommonSOLE
00445A100ACELYRIN INC$12.4M2.39%2,523,022CommonSOLE
21217B100CTNMCONTINEUM THERAPEUTICS INC$11.3M2.17%588,816CommonSOLE
471871202JSPRJASPER THERAPEUTICS INC$11.0M2.11%584,642CommonSOLE
00370M103ABVXABIVAX SA$9.8M1.88%850,000CommonSOLE
76243J105RYTMRHYTHM PHARMACEUTICALS INC$9.0M1.74%172,647CommonSOLE
45790W108INOZYME PHARMA INC$8.2M1.57%1,562,500CommonSOLE
869367102SUTRO BIOPHARMA INC$7.6M1.46%2,196,814CommonSOLE
52187K200CYPHLEAP THERAPEUTICS INC$6.3M1.21%2,442,352CommonSOLE
38341P102GOSSGOSSAMER BIO INC$6.0M1.16%6,130,268CommonSOLE
925050106VRNAVERONA PHARMA PLC$5.6M1.08%195,225CommonSOLE
87583X109TNGXTANGO THERAPEUTICS INC$4.9M0.93%630,000CommonSOLE
04317A107ARTVARTIVA BIOTHERAPEUTICS INC$4.5M0.87%291,666CommonSOLE
87184Q206SYRSSYROS PHARMACEUTICALS INC$3.8M0.74%1,786,427CommonSOLE
449778109IOBTQIO BIOTECH INC$3.8M0.73%3,640,015CommonSOLE
918385204VTVTVTV THERAPEUTICS INC$2.8M0.54%206,784CommonSOLE
N44445109IMTXIMMATICS N.V$2.3M0.43%198,000CommonSOLE
74168J101PRMEPRIME MEDICINE INC$2.1M0.40%540,304CommonSOLE
23954D109DAWNGBXDAY ONE BIOPHARMACEUTICALS I$2.1M0.39%147,319CommonSOLE
880881107430TERNS PHARMACEUTICALS INC$1.7M0.32%202,348CommonSOLE
43157M102HILLEVAX INC$1.4M0.27%799,274CommonSOLE
47103J105JANXJANUX THERAPEUTICS INC$1.0M0.20%22,526CommonSOLE
055477103BCAXBICARA THERAPEUTICS INC$891,4500.17%35,000CommonSOLE
00461U105ACRSACLARIS THERAPEUTICS INC$800,5970.15%696,171CommonSOLE
55234L105LYRAGBPLYRA THERAPEUTICS INC$714,5270.14%2,780,261CommonSOLE
097702104BOLT1EURBOLT BIOTHERAPEUTICS INC$679,8510.13%1,049,153CommonSOLE
92765F108RYIVIRACTA THERAPEUTICS INC$159,5990.03%689,709CommonSOLE
01671P100ALLKGUSDALLAKOS INC$112,4090.02%172,089CommonSOLE
50107A104KRON1USDKRONOS BIO INC$78,1230.02%78,131CommonSOLE
019818103ALLOVIR INC$66,5690.01%82,336CommonSOLE
67080N119NUVB/WSNUVATION BIO INC$13,0530.00%133,333CommonSOLE
86889P117SRZNWSURROZEN INC$1,0300.00%99,999CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.